Novo Nordisk: Compounded Semaglutide Sales Violate State Unfair Competition Laws
SHERMAN, Texas — Novo Nordisk Inc. is seeking a permanent injunction barring a compounding pharmacy from selling certain compounded semaglutide products, alleging in an amended complaint filed in a Texas federal...To view the full article, register now.
Already a subscriber? Click here to view full article